Effects of serial levosimendan infusions on left ventricular performance and plasma biomarkers of myocardial injury and neurohormonal and immune activation in patients with advanced heart failure

BACKGROUND: Levosimendan is a novel inodilator that improves central haemodynamics and symptoms of patients with decompensated chronic heart failure. The role, however, of repeated levosimendan infusions in the management of these patients has not yet been properly assessed. PURPOSE: This randomised...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Parissis, J T, Adamopoulos, S, Farmakis, D, Filippatos, G, Paraskevaidis, I, Panou, F, Iliodromitis, E, Kremastinos, D Th
Format: Artigo
Idioma:Inglês
Publicat: BMJ Group 2006
Matèries:
Cardiovascular Medicine
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC1861282/
https://ncbi.nlm.nih.gov/pubmed/17105880
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/hrt.2006.079707
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars